P-764 Phase II study of topotecan plus gemcitabine in previously treated small cell lung cancer (SCLC) patients: An Alpe-Adria Thoracic Oncology Multidisciplinary Group study (ATOM 012)

F Grossi,A Ardizzori,C Sacco,C Rossetto,A Sibau,S Tumolo,S Rizzato,A Piga,G Fasola,O Belvedere

doi:10.1016/s0169-5002(05)81257-7

P-764 Phase II study of topotecan plus gemcitabine in previously treated small cell lung cancer (SCLC) patients: An Alpe-Adria Thoracic Oncology Multidisciplinary Group study (ATOM 012)

F Grossi, A Ardizzori + Show 8 more

https://doi.org/10.1016/s0169-5002(05)81257-7

Copy DOI

Journal: Lung Cancer

Publication Date: Jul 1, 2005

#Small Cell Lung Cancer #Small Cell Lung Cancer Patients + Show 8 more

Abstract
Full-Text
Similar Papers

Abstract

P-764 Phase II study of topotecan plus gemcitabine in previously treated small cell lung cancer (SCLC) patients: An Alpe-Adria Thoracic Oncology Multidisciplinary Group study (ATOM 012)

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Similar Papers

Paper Title

Journal

Date

Author

View more papers

More From: Lung Cancer

Paper Title

Journal

Date

Author

View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.